Author/Authors :
Richard C Cook، نويسنده , , Joseph M Connors، نويسنده , , Randy D Gascoyne، نويسنده , , Guy Fradet، نويسنده , , Robert D Levy، نويسنده ,
Abstract :
Three patients with diffuse large B-cell type of post-transplant lymphoproliferative disease after lung transplantation were treated with rituximab, an anti-CD2O monoclonal antibody. Treatment resulted in two complete remissions and one nonresponse.
